166 related articles for article (PubMed ID: 35780452)
1. Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82).
Tabourin T; Pinar U; Parra J; Vaessen C; Bensalah CK; Audenet F; Bigot P; Champy C; Olivier J; Bruyere F; Doumerc N; Paparel P; Parier B; Nouhaud FX; Durand X; Lang H; Branger N; Long JA; Durand M; Waeckel T; Charles T; Cussenot O; Xylinas E; Boissier R; Tambwe R; Patard JJ; Bernhard JC; Roupret M
Ann Surg Oncol; 2022 Oct; 29(11):7218-7228. PubMed ID: 35780452
[TBL] [Abstract][Full Text] [Related]
2. Histological subtype of renal cell carcinoma significantly affects survival in the era of partial nephrectomy.
Nguyen DP; Vertosick EA; Corradi RB; Vilaseca A; Benfante NE; Touijer KA; Sjoberg DD; Russo P
Urol Oncol; 2016 Jun; 34(6):259.e1-8. PubMed ID: 26947350
[TBL] [Abstract][Full Text] [Related]
3. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors of recurrence after surgery in patients with non-metastatic renal cell carcinoma with venous tumor thrombus (UroCCR-56 Study).
Baboudjian M; Gondran-Tellier B; Khene Z; Bigot P; Mejean A; Lang H; Lebacle C; Doumerc N; Bruyere F; Nouhaud FX; Ouzaid I; Bensalah K; Bernhard JC; Boissier R
World J Urol; 2023 Feb; 41(2):295-302. PubMed ID: 33765164
[TBL] [Abstract][Full Text] [Related]
5. Overall survival and oncological outcomes after partial nephrectomy and radical nephrectomy for cT2a renal tumors: A collaborative international study from the French kidney cancer research network UroCCR.
Reix B; Bernhard JC; Patard JJ; Bigot P; Villers A; Suer E; Vuong NS; Verhoest G; Alimi Q; Beauval JB; Benoit T; Nouhaud FX; Lenormand C; Hamidi N; Cai J; Eto M; Larre S; El Bakhri A; Ploussard G; Hung A; Koutlidis N; Schneider A; Carrouget J; Droupy S; Marchal S; Doerfler A; Seddik S; Matsugasumi T; Orsoni X; Descazeaud A; Pfister C; Bensalah K; Soulie M; Gill I; Flamand V;
Prog Urol; 2018 Mar; 28(3):146-155. PubMed ID: 29331568
[TBL] [Abstract][Full Text] [Related]
6. Should patients with low-risk renal cell carcinoma be followed differently after nephron-sparing surgery vs radical nephrectomy?
Abu-Ghanem Y; Powles T; Capitanio U; Beisland C; Järvinen P; Stewart GD; Gudmundsson E; Lam TBL; Marconi L; Fernandéz-Pello S; Nisen H; Meijer RP; Volpe A; Ljungberg B; Klatte T; Bensalah K; Dabestani S; Bex A
BJU Int; 2021 Sep; 128(3):386-394. PubMed ID: 33794055
[TBL] [Abstract][Full Text] [Related]
7. Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years.
Tellini R; Antonelli A; Tardanico R; Fisogni S; Veccia A; Furlan MC; Carobbio F; Cozzoli A; Zanotelli T; Simeone C
Clin Genitourin Cancer; 2019 Feb; 17(1):e26-e31. PubMed ID: 30266249
[TBL] [Abstract][Full Text] [Related]
8. Local ablation vs partial nephrectomy in T1N0M0 renal cell carcinoma: An inverse probability of treatment weighting analysis.
Shi L; He Y; Liu C; Qian X; Wang Z
Cancer Med; 2020 Nov; 9(21):7988-8003. PubMed ID: 32888392
[TBL] [Abstract][Full Text] [Related]
9. Cancer control of partial nephrectomy for high-risk localized renal cell carcinoma: population-based and single-institutional analysis.
O'Malley RL; Hayn MH; Brewer KA; Underwood W; Hellenthal NJ; Kim HL; Sorokin I; Schwaab T
World J Urol; 2015 Nov; 33(11):1807-14. PubMed ID: 25805189
[TBL] [Abstract][Full Text] [Related]
10. A Multi-Institutional Analysis of the Effect of Positive Surgical Margins Following Robot-Assisted Partial Nephrectomy on Oncologic Outcomes.
Rothberg MB; Paulucci DJ; Okhawere KE; Reynolds CR; Badani KK; Abaza R; Eun D; Bhandari A; Porter J; Hemal AK
J Endourol; 2020 Mar; 34(3):304-311. PubMed ID: 31931607
[No Abstract] [Full Text] [Related]
11. Comparative analysis of partial versus radical nephrectomy for renal cell carcinoma: Is oncologic safety compromised during nephron sparing in higher stage disease?
Hakam N; Heidar NA; El-Asmar J; Khauli M; Degheili J; Al-Moussawy M; Nasr R; El-Hajj A; Wazzan W; Bulbul M; Khauli RB
Urol Ann; 2023; 15(2):226-231. PubMed ID: 37304513
[TBL] [Abstract][Full Text] [Related]
12. Comparison of prognosis between patients undergoing radical nephrectomy versus partial nephrectomy for renal cell carcinoma ≤7 cm T3aN0/xM0: Survival benefit is biased toward partial nephrectomy.
Liu S; Feng C; Liu C; Wang Z
Cancer Med; 2021 Dec; 10(24):8909-8923. PubMed ID: 34779154
[TBL] [Abstract][Full Text] [Related]
13. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J
Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098
[TBL] [Abstract][Full Text] [Related]
14. Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15).
Boulenger de Hauteclocque A; Ferrer L; Ambrosetti D; Ricard S; Bigot P; Bensalah K; Henon F; Doumerc N; Méjean A; Verkarre V; Dariane C; Larré S; Champy C; de La Taille A; Bruyère F; Rouprêt M; Paparel P; Droupy S; Fontenil A; Patard JJ; Durand X; Waeckel T; Lang H; Lebâcle C; Guy L; Pignot G; Durand M; Long JA; Charles T; Xylinas E; Boissier R; Yacoub M; Colin T; Bernhard JC
BJU Int; 2023 Aug; 132(2):160-169. PubMed ID: 36648124
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumour contour irregularity on surgical strategies for T1bN0M0 renal cell carcinoma: A multi-institutional study.
Xu P; Zhang S; Cheng J; Cao B; Huang J; Li Y; Lin W; Li H; Chen W; Zhu Y; Jiang S; Hu X; Wu J; Wu Z; Zhou J; Guo J; Cheng J; Wang H
Eur J Radiol; 2023 Feb; 159():110665. PubMed ID: 36566705
[TBL] [Abstract][Full Text] [Related]
16. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base.
Ristau BT; Handorf EA; Cahn DB; Kutikov A; Uzzo RG; Smaldone MC
Cancer; 2018 Oct; 124(19):3839-3848. PubMed ID: 30207380
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for recurrence after partial nephrectomy for clinical T1 renal cell carcinoma: a retrospective study of 1227 cases from a single institution.
Takagi T; Yoshida K; Wada A; Kondo T; Fukuda H; Ishihara H; Kobayashi H; Iizuka J; Okumi M; Ishida H; Nagashima Y; Tanabe K
Int J Clin Oncol; 2020 May; 25(5):892-898. PubMed ID: 32048086
[TBL] [Abstract][Full Text] [Related]
18. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T3a Renal Masses: A Multicenter Analysis.
Yim K; Aron M; Rha KH; Simone G; Minervini A; Challacombe B; Schips L; Berardinelli F; Quarto G; Mehrazin R; Patel D; Patel S; Bindayi A; Ashrafi AN; Desai M; Alqahtani A; Gallucci M; Sulek J; Mari A; De Luyk N; Anele U; Autorino R; Porpiglia F; Sundaram CP; Gill IS; Perdona S; Derweesh IH
Eur Urol Focus; 2021 Sep; 7(5):1107-1114. PubMed ID: 33249089
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data.
Erdem S; Bertolo R; Campi R; Capitanio U; Amparore D; Anceschi U; Mir MC; Roussel E; Pavan N; Carbonara U; Kara O; Klatte T; Marchioni M; Pecoraro A; Muselaers S; Marandino L; Diana P; Borregales L; Palumbo C; Warren H; Wu Z; Calio A; Ciccarese C; Degirmenci E; Aydin R; Rebez G; Schips L; Simone G; Minervini A; Serni S; Ozcan F
Urol Oncol; 2024 May; 42(5):163.e1-163.e13. PubMed ID: 38443238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
